Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Indiva Ltd NDVAF


Primary Symbol: V.NDVA

Healthcare
Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of... see more

Recent & Breaking News (TSXV:NDVA)

INDIVA REPORTS FIRST QUARTER 2022 RESULTS

PR Newswire May 19, 2022

INDIVA TO REPORT FIRST QUARTER RESULTS PRE-MARKET ON THURSDAY, MAY 19, 2022

PR Newswire May 10, 2022

Indiva to hold Investor Update Webinar, Monday May 2

Newsfile April 28, 2022

INDIVA REPORTS RECORD FOURTH QUARTER AND FISCAL YEAR 2021 RESULTS

PR Newswire April 26, 2022

INDIVA SIGNS EXCLUSIVE LICENSING AND MANUFACTURING AGREEMENT WITH DIME INDUSTRIES

PR Newswire April 19, 2022

Canntab Engages Hamish Sutherland as Strategic Advisor

PR Newswire April 13, 2022

INDIVA TO REPORT FOURTH QUARTER AND FULL YEAR RESULTS PRE-MARKET ON TUESDAY APRIL 26, 2022

PR Newswire April 7, 2022

INDIVA LAUNCHES NEW CANNABIS EDIBLE DESIGNED FOR MICRODOSING

PR Newswire February 24, 2022

INDIVA LAUNCHES NEW CANNABIS EDIBLE FORMULATED FOR NIGHT-TIME USE

PR Newswire February 15, 2022

Indiva to Hold Investor Webinar, Tomorrow Feb. 8

Newsfile February 7, 2022

INDIVA ANNOUNCES GRANT OF RESTRICTED SHARE UNITS

PR Newswire February 2, 2022

Indiva to Hold Investor Webinar, Feb. 8

Newsfile January 26, 2022

INDIVA ANNOUNCES APPOINTMENT OF NEW DIRECTOR, INCENTIVE STOCK OPTION GRANT, CHANGE OF AUDITOR AND INTEREST PAYMENT ON DEBENTURE

PR Newswire December 16, 2021

INDIVA SIGNS EXCLUSIVE LICENSING AND MANUFACTURING AGREEMENT WITH GRÖN

PR Newswire December 15, 2021

Stocks2Watch to Host Indiva Investor Update Tomorrow, December 2nd

Newsfile December 1, 2021

Indiva Reports Third Quarter Fiscal 2021 Results

PR Newswire November 16, 2021

Indiva to Report Third Quarter Results Pre-market on Tuesday November 16th

PR Newswire November 8, 2021

Indiva Announces Increase and Amendment to Term Loan Facility with Sundial Growers Inc. Providing Additional Non-Dilutive Capital

PR Newswire October 5, 2021

Indiva Announces Warrant Incentive Program

PR Newswire September 22, 2021

Indiva Reports Second Quarter Fiscal 2021 Results

PR Newswire August 24, 2021